Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adaptive Biotechnologies Corp (ADPT) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptive Biotechnologies Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1478320.
Total stock buying since 2019: $15,244,000.
Total stock sales since 2019: $1,191,021,204.
Total stock option exercises since 2019: $36,672,527.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,345,234 | $19,039,812 | 1,818,901 | $11,382,947 |
| 2024 | 0 | $0 | 208,558 | $747,749 | 20,000 | $22,500 |
| 2023 | 0 | $0 | 371,811 | $3,040,391 | 302,289 | $1,197,659 |
| 2022 | 0 | $0 | 149,445 | $1,629,238 | 44,445 | $280,890 |
| 2021 | 0 | $0 | 2,680,192 | $137,995,448 | 1,682,742 | $12,377,740 |
| 2020 | 0 | $0 | 28,716,845 | $1,018,663,741 | 3,163,148 | $11,125,841 |
| 2019 | 762,200 | $15,244,000 | 335,000 | $9,904,825 | 375,000 | $284,950 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-19 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-11-18 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 47.61 | 794,184 |
| 2020-11-18 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-11-17 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 46.26 | 771,616 |
| 2020-11-17 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-11-16 | Lo Francis (Chief People Officer) | Sale | 2,000 | 47.94 | 95,880 |
| 2020-11-16 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2020-11-16 | Hershberg Robert (Director) | Sale | 2,000 | 48.01 | 96,010 |
| 2020-11-16 | Hershberg Robert (Director) | Option Ex | 2,000 | .45 | 900 |
| 2020-11-16 | Griffin Michelle Renee (Director) | Sale | 6,000 | 47.94 | 287,610 |
| 2020-11-16 | Griffin Michelle Renee (Director) | Option Ex | 6,000 | 7.80 | 46,800 |
| 2020-11-11 | Shabet Rose Sharon | Sale | 5,000,000 | 49.52 | 247,575,000 |
| 2020-11-09 | Cohen Chad M (Chief Financial Officer) | Sale | 30,000 | 49.74 | 1,492,200 |
| 2020-11-09 | Cohen Chad M (Chief Financial Officer) | Option Ex | 30,000 | 6.32 | 189,600 |
| 2020-11-06 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 51.52 | 571,838 |
| 2020-11-06 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-11-06 | Baldo Lance (Chief Medical Officer) | Sale | 6,250 | 50.90 | 318,125 |
| 2020-11-06 | Baldo Lance (Chief Medical Officer) | Option Ex | 6,250 | 7.80 | 48,750 |
| 2020-11-05 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 50.44 | 559,884 |
| 2020-11-05 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-11-04 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 50.59 | 561,549 |
| 2020-11-04 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-11-02 | Benzeno Sharon (Chief Business Development Officer) | Sale | 6,772 | 45.80 | 310,191 |
| 2020-11-02 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 6,772 | 6.79 | 45,981 |
| 2020-10-26 | Taylor Stacy L (SVP and General Counsel) | Sale | 2,880 | 49.53 | 142,660 |
| 2020-10-26 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 2,880 | 7.17 | 20,664 |
| 2020-10-19 | Benzeno Sharon (Chief Business Development Officer) | Sale | 417 | 51.25 | 21,371 |
| 2020-10-19 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 417 | 6.27 | 2,614 |
| 2020-10-16 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 51.79 | 574,869 |
| 2020-10-16 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-10-15 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 51.55 | 572,205 |
| 2020-10-15 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-10-15 | Lo Francis (Chief People Officer) | Sale | 2,000 | 51.51 | 103,020 |
| 2020-10-15 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2020-10-15 | Hershberg Robert (Director) | Sale | 2,000 | 51.51 | 103,020 |
| 2020-10-15 | Hershberg Robert (Director) | Option Ex | 2,000 | .45 | 900 |
| 2020-10-14 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 52.35 | 581,140 |
| 2020-10-14 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-10-14 | Pellini Michael J (Director) | Sale | 50,000 | 52.42 | 2,621,000 |
| 2020-10-14 | Pellini Michael J (Director) | Option Ex | 50,000 | 6.55 | 327,500 |
| 2020-10-14 | Griffin Michelle Renee (Director) | Sale | 12,000 | 52.77 | 633,300 |
| 2020-10-14 | Griffin Michelle Renee (Director) | Option Ex | 12,000 | 7.80 | 93,600 |
| 2020-10-12 | Lo Francis (Chief People Officer) | Sale | 25,000 | 52.80 | 1,320,000 |
| 2020-10-12 | Lo Francis (Chief People Officer) | Option Ex | 25,000 | 7.80 | 195,000 |
| 2020-10-08 | Robins Chad M (CEO and Chairman) | Sale | 24,260 | 50.97 | 1,236,410 |
| 2020-10-08 | Robins Chad M (CEO and Chairman) | Option Ex | 24,260 | .33 | 8,005 |
| 2020-10-08 | Cohen Chad M (Chief Financial Officer) | Sale | 30,000 | 50.91 | 1,527,300 |
| 2020-10-08 | Cohen Chad M (Chief Financial Officer) | Option Ex | 30,000 | 6.32 | 189,600 |
| 2020-10-07 | Robins Chad M (CEO and Chairman) | Sale | 50,000 | 49.80 | 2,490,000 |
| 2020-10-07 | Robins Chad M (CEO and Chairman) | Option Ex | 50,000 | .33 | 16,500 |
| 2020-10-06 | Baldo Lance (Chief Medical Officer) | Sale | 6,250 | 49.37 | 308,562 |
| 2020-10-06 | Baldo Lance (Chief Medical Officer) | Option Ex | 6,250 | 7.80 | 48,750 |
| 2020-10-06 | Robins Chad M (CEO and Chairman) | Sale | 18,280 | 49.41 | 903,214 |
| 2020-10-06 | Robins Chad M (CEO and Chairman) | Option Ex | 18,280 | .33 | 6,032 |
| 2020-10-01 | Benzeno Sharon (Chief Business Development Officer) | Sale | 6,771 | 48.86 | 330,831 |
| 2020-10-01 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 6,771 | 6.79 | 45,975 |
| 2020-10-01 | Rubinstein Julie (President) | Sale | 14,725 | 49.00 | 721,525 |
| 2020-10-01 | Rubinstein Julie (President) | Option Ex | 14,725 | .84 | 12,369 |
| 2020-10-01 | Robins Chad M (CEO and Chairman) | Sale | 600 | 50.05 | 30,030 |
| 2020-10-01 | Robins Chad M (CEO and Chairman) | Option Ex | 600 | .33 | 198 |
| 2020-10-01 | Dobmeier Eric (Director) | Sale | 10,000 | 48.84 | 488,400 |
| 2020-10-01 | Dobmeier Eric (Director) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2020-09-29 | Bobulsky Susan (SVP, Diagnostics, clonoSEQ) | Sale | 10,000 | 50.00 | 500,000 |
| 2020-09-29 | Bobulsky Susan (SVP, Diagnostics, clonoSEQ) | Option Ex | 10,000 | 1.98 | 19,800 |
| 2020-09-29 | Baldo Lance (Chief Medical Officer) | Sale | 25,000 | 50.00 | 1,250,000 |
| 2020-09-29 | Baldo Lance (Chief Medical Officer) | Option Ex | 25,000 | 7.80 | 195,000 |
| 2020-09-29 | Rubinstein Julie (President) | Sale | 80,000 | 49.00 | 3,920,000 |
| 2020-09-29 | Rubinstein Julie (President) | Option Ex | 80,000 | .84 | 67,200 |
| 2020-09-29 | Robins Chad M (CEO and Chairman) | Sale | 1,900 | 50.18 | 95,342 |
| 2020-09-29 | Robins Chad M (CEO and Chairman) | Option Ex | 1,900 | .33 | 627 |
| 2020-09-24 | Taylor Stacy L (SVP and General Counsel) | Sale | 2,880 | 48.04 | 138,355 |
| 2020-09-24 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 2,880 | 7.17 | 20,664 |
| 2020-09-24 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 47.09 | 522,665 |
| 2020-09-24 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-09-23 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 48.16 | 534,576 |
| 2020-09-23 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-09-22 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 47.65 | 528,859 |
| 2020-09-22 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-09-21 | Benzeno Sharon (Chief Business Development Officer) | Sale | 417 | 45.51 | 18,977 |
| 2020-09-21 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 417 | 6.27 | 2,614 |
| 2020-09-18 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 45.70 | 762,359 |
| 2020-09-18 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-09-17 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 44.87 | 748,431 |
| 2020-09-17 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-09-16 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 46.91 | 782,458 |
| 2020-09-16 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-09-15 | Lo Francis (Chief People Officer) | Sale | 2,000 | 42.58 | 85,160 |
| 2020-09-15 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2020-09-15 | Sang Charles (SVP, External Affairs) | Sale | 25,000 | 44.00 | 1,100,000 |
| 2020-09-15 | Sang Charles (SVP, External Affairs) | Option Ex | 25,000 | 6.32 | 158,000 |
| 2020-09-15 | Hershberg Robert (Director) | Sale | 2,000 | 42.58 | 85,160 |
| 2020-09-15 | Hershberg Robert (Director) | Option Ex | 2,000 | .45 | 900 |
| 2020-09-14 | Sang Charles (SVP, External Affairs) | Sale | 25,000 | 42.50 | 1,062,500 |
| 2020-09-14 | Sang Charles (SVP, External Affairs) | Option Ex | 25,000 | 6.55 | 163,750 |
| 2020-09-11 | Baldo Lance (Chief Medical Officer) | Sale | 4,149 | 40.00 | 165,960 |
| 2020-09-11 | Baldo Lance (Chief Medical Officer) | Option Ex | 4,149 | 7.80 | 32,362 |
| 2020-09-11 | Cohen Chad M (Chief Financial Officer) | Sale | 8,588 | 40.00 | 343,520 |
| 2020-09-11 | Cohen Chad M (Chief Financial Officer) | Option Ex | 8,588 | 6.32 | 54,276 |
| 2020-09-10 | Baldo Lance (Chief Medical Officer) | Sale | 18 | 40.00 | 720 |
| 2020-09-10 | Baldo Lance (Chief Medical Officer) | Option Ex | 18 | 7.80 | 140 |
| 2020-09-10 | Cohen Chad M (Chief Financial Officer) | Sale | 1,412 | 40.00 | 56,480 |
| 2020-09-10 | Cohen Chad M (Chief Financial Officer) | Option Ex | 1,412 | 6.32 | 8,923 |
| 2020-09-08 | Baldo Lance (Chief Medical Officer) | Sale | 2,083 | 36.17 | 75,342 |
| 2020-09-08 | Baldo Lance (Chief Medical Officer) | Option Ex | 2,083 | 7.80 | 16,247 |
| 2020-09-08 | Cohen Chad M (Chief Financial Officer) | Sale | 20,000 | 36.17 | 723,400 |
| 2020-09-08 | Cohen Chad M (Chief Financial Officer) | Option Ex | 20,000 | 6.32 | 126,400 |
| 2020-09-01 | Benzeno Sharon (Chief Business Development Officer) | Sale | 6,771 | 41.52 | 281,098 |
| 2020-09-01 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 6,771 | 6.79 | 45,975 |
| 2020-08-24 | Taylor Stacy L (SVP and General Counsel) | Sale | 2,880 | 42.78 | 123,215 |
| 2020-08-24 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 2,880 | 7.17 | 20,664 |
| 2020-08-21 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 42.86 | 475,746 |
| 2020-08-21 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-08-20 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 42.99 | 477,189 |
| 2020-08-20 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-08-19 | Benzeno Sharon (Chief Business Development Officer) | Sale | 416 | 41.57 | 17,293 |
| 2020-08-19 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 416 | 6.27 | 2,608 |
| 2020-08-19 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 42.34 | 469,974 |
| 2020-08-19 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 11,100 | 6.32 | 70,152 |
| 2020-08-17 | Lo Francis (Chief People Officer) | Sale | 2,000 | 39.56 | 79,120 |
| 2020-08-17 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2020-08-17 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 40.00 | 400,000 |
| 2020-08-17 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2020-08-17 | Hershberg Robert (Director) | Sale | 2,000 | 39.59 | 79,170 |
| 2020-08-17 | Hershberg Robert (Director) | Option Ex | 2,000 | .45 | 900 |
| 2020-08-12 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 37.58 | 626,784 |
| 2020-08-12 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-08-11 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 37.29 | 621,997 |
| 2020-08-11 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-08-10 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 37.63 | 627,668 |
| 2020-08-10 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-08-10 | Cohen Chad M (Chief Financial Officer) | Sale | 20,000 | 37.78 | 755,600 |
| 2020-08-10 | Cohen Chad M (Chief Financial Officer) | Option Ex | 20,000 | 6.32 | 126,400 |
| 2020-08-06 | Baldo Lance (Chief Medical Officer) | Sale | 6,250 | 40.00 | 250,000 |
| 2020-08-06 | Baldo Lance (Chief Medical Officer) | Option Ex | 6,250 | 7.80 | 48,750 |
| 2020-08-04 | Benzeno Sharon (Chief Business Development Officer) | Sale | 7,187 | 40.00 | 287,480 |
| 2020-08-04 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 7,187 | 6.67 | 47,951 |
| 2020-08-03 | Hill Nancy Louise (EVP, Operations & Program Mana) | Sale | 1,600 | 37.37 | 59,791 |
| 2020-08-03 | Hill Nancy Louise (EVP, Operations & Program Mana) | Option Ex | 1,600 | .84 | 1,344 |
| 2020-07-31 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 37.49 | 625,333 |
| 2020-07-31 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-07-30 | Robins Chad M (CEO and Chairman) | Sale | 16,680 | 37.72 | 629,169 |
| 2020-07-30 | Robins Chad M (CEO and Chairman) | Option Ex | 16,680 | .33 | 5,504 |
| 2020-07-29 | Robins Chad M (CEO and Chairman) | Sale | 20,668 | 38.14 | 788,277 |
| 2020-07-29 | Robins Chad M (CEO and Chairman) | Option Ex | 20,668 | .33 | 6,820 |
| 2020-07-24 | Taylor Stacy L (SVP and General Counsel) | Sale | 2,880 | 36.03 | 103,766 |
| 2020-07-24 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 2,880 | 7.17 | 20,664 |
| 2020-07-20 | Benzeno Sharon (Chief Business Development Officer) | Sale | 417 | 40.00 | 16,680 |
| 2020-07-20 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 417 | 6.27 | 2,614 |
| 2020-07-20 | Matrix Capital Management Company, Lp | Sale | 2,000,000 | 40.00 | 80,000,000 |
| 2020-07-17 | Robins Harlan S (Chief Scientific Officer) | Sale | 11,100 | 39.49 | 438,305 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptive Biotechnologies Corp (symbol ADPT, CIK number 1478320) see the Securities and Exchange Commission (SEC) website.